Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005235-14Phase 4Completed
Phase 4, randomised trial of Suboxone and buprenorphine in opioid use disorder (OUD) and substance use disorder (SUD) (2 arms), sponsored by Integrated Therapeutics Group. Primary endpoint: Response rate at Day 3. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005235-14.